Cambrex Industry Insights
-
Components Of An Effective Disinfectant Prequalification Strategy
1/24/2022
Cleaning procedures designed specifically to destroy microbial contaminants that may be present are an important component of any microbial control strategy.
-
Painkiller And Sedative Demands: Effects On Bupivacaine HCI Supply
1/20/2022
As global authorities work to fill gaps, drug manufacturers and CDMOs have become critical in the efforts to stabilize the supply of Bupivacaine HCl and other essential drugs.
-
Design Of Experiments Approach To Enabling Studies For Process Validation
A recent project applied process improvement methodology to the process validation step that ultimately provided not only an optimized, robust process but also an economic advantage.
-
End-To-End Development And Manufacturing: Small Volume Commercial Products
To meet ambitious orphan drug development timelines, CDMOs must be able to scale quickly to progress from early clinical development to validation and commercial launch.
-
Post-Pandemic Outsourcing Demand: How Are CDMOs Responding?
Ultimately, to serve the highly competitive biopharma and pharmaceutical markets, CDMOs must be adaptable to the culture of the company for whom they are working.
-
Two Steps Forward, One Step Back: IND Submission In Early Development
A panel of product development experts examines blind spots that can plague early development strategies, as well as important considerations when navigating the path toward an IND submission.